← Open Payments lookup

RYAN C NOKES: Open Payments

NPI 1053773739 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,007 in 101 payments from 13 companies in 2025. Trend: 2023 $833 · 2024 $2,315 · 2025 $3,007

Food & beverage: $3,004Education: $3
CompanyPaymentsAmount
ABBVIE INC.30$829
Alkermes, Inc.17$615
Neurocrine BioSciences, Inc.14$479
E.R. Squibb & Sons, L.L.C.9$237
Otsuka America Pharmaceutical, Inc.12$236
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$173
Vanda Pharmaceuticals Inc.5$141
Janssen Scientific Affairs, LLC1$115
Axsome Therapeutics, Inc.4$85
Sage Therapeutics, LLC3$47

Products named: VRAYLAR, ARISTADA, INGREZZA, COBENFY, CAPLYTA, FANAPT, REXULTI, INVEGA SUSTENNA.

Industry payments across NV — which companies pay providers there.